Timothy E Wilens Selected Research

pozanicline

1/2011	Safety and efficacy of ABT-089 in pediatric attention-deficit/hyperactivity disorder: results from two randomized placebo-controlled clinical trials.
10/2007	Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition.
6/2006	ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Timothy E Wilens Research Topics

Disease

74	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2022 - 01/2002
26	Substance-Related Disorders (Drug Abuse) 01/2022 - 01/2002
5	Mental Disorders (Mental Disorder) 01/2022 - 01/2003
5	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 01/2018
5	Alcoholism (Alcohol Abuse) 01/2020 - 01/2002
5	Bipolar Disorder (Manic Depressive Psychosis) 10/2009 - 07/2003
4	Mania (Manias) 10/2009 - 07/2003
3	Mood Disorders (Mood Disorder) 01/2019 - 10/2005
3	Nausea 11/2017 - 07/2006
2	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 02/2006
2	Opiate Overdose 01/2020 - 01/2018
2	Vomiting 11/2017 - 10/2007
2	Epilepsy (Aura) 11/2017 - 07/2006
2	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2012 - 10/2006
2	Tobacco Use Disorder (Nicotine Dependence) 05/2008 - 02/2006
2	Hypertension (High Blood Pressure) 05/2006 - 01/2002
2	Tics (Tic) 02/2006 - 01/2002
1	Autism Spectrum Disorder 01/2022
1	Autistic Disorder (Autism) 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2022
1	Intellectual Disability (Idiocy) 01/2022
1	Neonatal Abstinence Syndrome 01/2020
1	Birth Weight (Birth Weights) 01/2020
1	Prescription Drug Misuse 01/2019
1	Feeding and Eating Disorders (Eating Disorder) 05/2018
1	Acute Pain 06/2017
1	Sudden Death 09/2006
1	Diplopia (Double Vision) 07/2006
1	Exanthema (Rash) 07/2006
1	Fatigue 07/2006
1	Sleepiness 07/2006
1	Dizziness (Lightheadedness) 07/2006
1	Essential Hypertension 05/2006
1	Anxiety Disorders (Anxiety Disorder) 02/2006
1	Elimination Disorders 02/2006
1	Body Weight (Weight, Body) 02/2006
1	Antisocial Personality Disorder (Antisocial Personality) 02/2006
1	Constipation 01/2002

Drug/Important Bio-Agent (IBA)

16	Methylphenidate (Ritalin)FDA LinkGeneric 03/2022 - 03/2002
15	Pharmaceutical PreparationsIBA 01/2020 - 01/2003
12	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2022 - 01/2002
10	Amphetamine (Amfetamine)FDA LinkGeneric 05/2018 - 03/2002
9	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2002
6	Bupropion (Wellbutrin)FDA LinkGeneric 04/2010 - 01/2002
6	SaltsIBA 08/2006 - 09/2005
5	Buprenorphine (Subutex)FDA LinkGeneric 10/2021 - 06/2017
5	Antidepressive Agents (Antidepressants)IBA 10/2011 - 01/2002
5	Antihypertensive Agents (Antihypertensives)IBA 05/2006 - 01/2002
4	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2007 - 01/2002
3	Hypnotics and Sedatives (Sedatives)IBA 01/2022 - 03/2018
3	Methadone (Dolophine)FDA LinkGeneric 10/2021 - 01/2018
3	Guanfacine (Tenex)FDA LinkGeneric 01/2017 - 01/2012
3	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2011 - 06/2006
3	pozaniclineIBA 01/2011 - 06/2006
3	Nicotine FDA Link 09/2008 - 10/2007
3	Delayed-Action PreparationsIBA 01/2008 - 09/2005
3	Dopamine (Intropin)FDA LinkGeneric 10/2007 - 01/2002
2	Cocaine (Cocaine HCl)IBA 01/2021 - 05/2018
2	Prescription DrugsIBA 01/2019 - 03/2018
2	Histamine (Histamine Dihydrochloride)FDA Link 07/2012 - 06/2008
2	Valproic Acid (Depakote)FDA LinkGeneric 05/2009 - 02/2009
2	Biological ProductsIBA 10/2008 - 09/2006
2	SLI381IBA 02/2006 - 09/2005
2	Wakefulness-Promoting AgentsIBA 01/2003 - 03/2002
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2003 - 01/2002
2	Amino Acids FDA Link 01/2003 - 03/2002
1	CannabidiolIBA 01/2022
1	mesoglycanIBA 01/2022
1	nasIBA 01/2020
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2019
1	Heroin (Diamorphine)IBA 06/2018
1	Naloxone Drug Combination Buprenorphine FDA Link 06/2018
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2017
1	Lisdexamfetamine Dimesylate FDA Link 05/2013
1	MK-0249IBA 07/2012
1	Dihydrotachysterol (AT 10)IBA 05/2010
1	Antipsychotic Agents (Antipsychotics)IBA 10/2009
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2009
1	GSK372475IBA 06/2008
1	Acetylcholine (Acetylcholine Chloride)FDA Link 06/2008
1	Serotonin (5 Hydroxytryptamine)IBA 06/2008
1	CatecholaminesIBA 06/2008
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2008
1	3- methyl- 5- (1- methyl- 2- pyrrolidinyl)isoxazoleIBA 10/2007
1	Cholinergic Agents (Cholinergics)IBA 10/2007
1	Mirtazapine (Rexer)FDA LinkGeneric 10/2006
1	Oxcarbazepine (Trileptal)FDA LinkGeneric 07/2006
1	SmokeIBA 02/2006
1	Illicit Drugs (Recreational Drugs)IBA 02/2006
1	Donepezil (Aricept)FDA LinkGeneric 12/2005
1	Desipramine (Pertofrane)FDA LinkGeneric 02/2005
1	Dopamine Agents (Dopaminergic Agents)IBA 10/2004
1	A-factor (Streptomyces)IBA 01/2004
1	Pemoline (Cylert)FDA Link 03/2002
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 01/2002

Therapy/Procedure

25	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
12	Therapeutics 01/2021 - 01/2003
3	Self Medication 01/2007 - 01/2004
1	Duration of Therapy 01/2021
1	Diet Therapy (Therapy, Diet) 01/2002